Gabapentin Enacarbil (GSK1838262) Adult Restless Leg Syndrome (RLS) Post Marketing Commitment Study

Clinical trial NCT01668667 · COMPLETED

Trial details

NCT number: NCT01668667
Sponsor: XenoPort, Inc.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Restless Legs Syndrome

Start date: 2012-06-01
Primary completion: 2013-11-01
Enrollment: 501

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.